Discover
GMED
Globus Medical, Inc.
75.96
500 x undefined
600 x undefined
bid
ask
-
3.05
3.86%
550 @ 05:45 AM
76.90 +0.94 (1.24%)
| Ytd | -13.00% | |
| 1y | 26.18% |
75.14
day range
80.21
51.79
52 week range
101.40
| Open | 79.47 | Prev Close | 79.01 | Low | 75.14 | High | 80.21 | Mkt Cap | 10.31B |
| Vol | 2.66M | Avg Vol | 1.65M | EPS | 4.28 | P/E | 17.75 | Forward P/E | 14.76 |
| Beta | 0.95 | Short Ratio | 3.09 | Inst. Own | 101.40% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 83.01 | 200-d Avg | 81.78 | 1yr Est | 108.64 |
GMED News
zacks.com
Here's Why Globus Medical (GMED) is a Strong Momentum Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investi
benzinga.com
AI Chips Power Wall Street Higher, Dow Eyes Records: Stock Market Today
Tech and semis lead the S&P 500 and Nasdaq higher into quarter-end
zacks.com
GMED vs. MDT: Which Medical Stock Has More Upside Potential?
Globus Medical or Medtronic? See why Globus Medical's stronger growth, innovation and analyst upside
zacks.com
Why Globus Medical (GMED) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investi
benzinga.com
Paychex To Rally More Than 39%? Here Are 10 Top Analyst Forecasts For Monday
Top Wall Street analysts changed their outlook on top names. See all rating changes on our analyst r
benzinga.com
Piper Sandler Maintains Overweight on Globus Medical, Lowers Price Target to $100
Piper Sandler analyst Matt O'Brien maintains Globus Medical (NYSE:GMED) with a Overweight and